Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $9,238 | $13,133 | $15,389 | $13,271 |
| - Cash | $420 | $434 | $370 | $318 |
| + Debt | $238 | $250 | $250 | $254 |
| Enterprise Value | $9,056 | $12,949 | $15,269 | $13,207 |
| Revenue | $385 | $582 | $490 | $504 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Gross Profit | $242 | $360 | $303 | $324 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| EBITDA | $28 | $222 | $111 | $123 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |
| Net Income | $4 | $159 | $45 | $48 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| % Growth | -97.5% | 253.6% | -6.7% | – |
| Operating Cash Flow | $43 | $162 | $109 | $34 |
| Capital Expenditures | -$32 | -$37 | -$48 | -$43 |
| Free Cash Flow | $11 | $125 | $61 | -$9 |